Chipscreen biosciences pipeline
WebAug 12, 2024 · Chipscreen Biosciences (688321.SH) is a clinical stage biotech company that is developing therapies for cancer and metabolic disorders. Among its late stage pipeline, CS055 is a histone deacetylase (HDAC) inhibitor, currently in Phase III clinical trials in China for non-Hodgkin's lymphoma (NHL). Headquarters Location WebChipscreen Biosciences focuses on cancer therapies. Chidamide ( Tusidinostat, Epidaza ® ), the first original innovative drug discovered and developed by Chipscreen, was the first oral subtype-selective histone …
Chipscreen biosciences pipeline
Did you know?
WebFeb 23, 2024 · The U.S. Department of Transportation’s Pipeline and Hazardous Materials Safety Administration (PHMSA) provides online maps to help you locate pipelines in or … WebFeb 27, 2024 · Chipscreen NewWay, affiliated with Chipscreen, is an innovative and R&D-driven biotech company dedicated to developing large molecules and other novel …
WebChiauranib is an innovative, 3-pathway targeted kinase small molecule inhibitor with high selectivity against Auroa B /VEGFRs/CSF1R currently entering Phase III clinical trials in China. Lead Product (s): Chiauranib. Therapeutic Area: Oncology Product Name: CS2164. Highest Development Status: Phase III Product Type: Small molecule. WebFeb 18, 2024 · With the self-created "integrated drug discovery and early evaluation platform based on chemical genetics" as its core competitiveness, Chipscreen Biosciences has now become one of China's leading innovative drug enterprises, forming a modern biomedicine group company in Shenzhen, as its headquarters / research and …
WebJun 24, 2024 · SHENZHEN, China, June 24, 2024 /PRNewswire/ -- Shenzhen Chipscreen Biosciences' licensing partner, HUYABIO International (HUYABIO™), today announced the regulatory approval for Tucidinostat... WebFeb 27, 2024 · Under the agreement, Chipscreen NewWay will pay Eucure Biopharma an upfront payment of 40 million RMB, a potential development milestone payment of up to 360 million RMB, a potential sales...
WebFeb 27, 2024 · About Chipscreen NewWay Biosciences. Chipscreen NewWay, affiliated with Chipscreen, is an innovative and R&D-driven biotech company dedicated to …
WebFeb 27, 2024 · Chipscreen NewWay, affiliated with Chipscreen, is an innovative and R&D-driven biotech company dedicated to developing large molecules and other novel therapeutic modalities, including... ons hofje oirschotWebMar 23, 2024 · Dublin, March 23, 2024 (GLOBE NEWSWIRE) -- The "Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) - Pipeline Review, H1 2024" report has been added to ... iobroker trashscheduleWebMontgomery County, Kansas. / 37.200°N 95.733°W / 37.200; -95.733. / 37.200°N 95.733°W / 37.200; -95.733. Montgomery County (county code MG) is a county … ons hol amelandWebFeb 27, 2024 · “Chipscreen Biosciences and Chipscreen NewWay have extensive experience in clinical drug development and commercialization,” said Dr. Yuelei Shen, … iobroker time switchWebApr 14, 2024 · In March 2024, Akeso, Inc. announced that it has entered into a collaboration agreement with Shenzhen Chipscreen Biosciences, Ltd. (SHA Code 688321) to … on shoes zero dropWebNov 3, 2024 · CS 53001 is a small molecule P53 allosteric modulator, being developed by Chipscreen Biosciences for the treatment of cancer. p53 is a nuclear transcription CS 53001 ... (Chipscreen Biosciences pipeline, October 2024) Subscriber content You need to be a logged in subscriber to view this content. If ... iobroker trashschedule widgetWebOct 19, 2024 · Shenzhen Chipscreen Biosciences Co., Ltd. (Chipscreen Biosciences, Stock Symbol: 688321.SH) was founded in Shenzhen in 2001, specializing in the research and development of novel small molecule drugs. iobroker timeout